Topical promethazine side effects: Our experience and review of the literature

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Cantisani, C ^a   Ricci, S ^a   Grieco, T ^a   Paolino, G ^a   Faina, V ^a   Silvestri, E ^a   Calvieri, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ARYLPROPIONIC ACID DERIVATIVE; BENZOPHENONE; DIAZEPAM; DIPHENHYDRAMINE; FENOFIBRATE; GLUCOCORTICOID; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITROPRUSSIDE SODIUM; OXYBENZONE; PHENYTOIN; PHYSOSTIGMINE; PROMETHAZINE; TIAPROFENIC ACID; ZINC OXIDE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGY; ANGIONEUROTIC EDEMA; ANXIETY DISORDER; ASTHMA; BLOOD BRAIN BARRIER; CONTACT DERMATITIS; DERMATITIS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INTOXICATION; DRUG METABOLISM; DYSTONIA; EDEMA; ERYTHEMA; ERYTHEMA MULTIFORME; GANGRENE; HUMAN; HYPERTENSION; JAUNDICE; LOWER RESPIRATORY TRACT INFECTION; MACULOPAPULAR RASH; MAXIMUM PLASMA CONCENTRATION; MOTION SICKNESS; PHARMACODYNAMICS; PHOTOALLERGY; PHOTODERMATOSIS; PHOTOPATCH TEST; PHOTOSENSITIVITY; PNEUMONIA; POSTINFLAMMATORY HYPERPIGMENTATION; POSTOPERATIVE NAUSEA AND VOMITING; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDERED BREATHING; SUDDEN INFANT DEATH SYNDROME; THROMBOCYTOPENIC PURPURA; URTICARIA; VEIN THROMBOSIS; VOMITING; DRUG EFFECT; EPIDERMIS; INFLAMMATION; METABOLISM; SKIN DISEASE;

EPIDERMIS; HISTAMINE H1 ANTAGONISTS; HUMANS; INFLAMMATION; PROMETHAZINE; SKIN DISEASES;

EID: 84890105932     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/151509     Document Type: Review

References (39)

1. Patel T., Yosipovitch G., The management of chronic pruritus in the elderly. Skin Therapy Letter 2010 15 8 5 9 2-s2.0-77958167293
2. Khan D. A., Solensky R., Drug allergy. Journal of Allergy and Clinical Immunology 2010 125 2 S126 S137 2-s2.0-76749157075 10.1016/j.jaci.2009.10.028
3. Ashmawi H. A., Braun L. M., Sousa A. M., Posso I. D. P., Analgesic effects of H1 receptor antagonists in the rat model of formalin-induced pain. Revista Brasileira de Anestesiologia 2009 59 4 461 470 2-s2.0-70349250306 10.1590/S0034-70942009000400008
4. Danarti R., Waskito F., Indrastuti N., Onset and duration of action of topical antihistamine: a study of histamine skin test response. International Journal of Dermatology 2008 47 8 861 863 2-s2.0-48249107171 10.1111/j.1365-4632. 2008.03639.x
5. Yanai K., Anticholinergic activity of antihistamines. Clinical Neurophysiology 2012 123 4 633 634 2-s2.0-84857784121 10.1016/j.clinph.2011.09. 005
6. Tarkkila P., Torn K., Tuominen M., Lindgren L., Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine. Acta Anaesthesiologica Scandinavica 1995 39 7 983 986 2-s2.0-0029152242
7. Scherl E. R., Wilson J. F., Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995 35 5 256 259 2-s2.0-0029012229 10.1111/j.1526-4610.1995. hed3505256.x
8. Buzdar A. U., Esparza L., Natale R., Cody R., Calzone K., Benson A. B. III, Sheehan T., Berry W., Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine: a placebo-controlled study. American Journal of Clinical Oncology 1994 17 5 417 421 2-s2.0-0027941195 (Pubitemid 24298947)
9. Lackner J. R., Graybiel A., Use of promethazine to hasten adaptation to provocative motion. Journal of Clinical Pharmacology 1994 34 6 644 648 2-s2.0-0028242841 (Pubitemid 24187984)
10. Terndrup T. E., Dire D. J., Madden C. M., Davis H., Cantor R. M., Gavula D. P., A prospective analysis of intramuscular meperidine, promethazine, and chlorpromazine in pediatric emergency department patients. Annals of Emergency Medicine 1991 20 1 31 35 2-s2.0-0026017377 10.1016/S0196-0644(05)81114-X
11. Lin T. K., Man M. Q., Santiago J. L., Park K., Roelandt T., Oda Y., Hupe M., Crumrine D., Lee H. J., Gschwandtner M., Thyssen J. P., Trullas C., Tschachler E., Feingold K. R., Elias P. M., Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. Journal of Investigative Dermatology 2013 133 2 469 478
12. Ljubojević S., Lipozencić J., Reactions to insect stings and bites. Acta Medica Croatica 2011 65 2 137 139
13. Blaya B., Nicolau-Galmés F., Jangi S. M., Ortega-Martínez I., Alonso-Tejerina E., Burgos-Bretones J., Pérez-Yarza G., Asumendi A., Boyano M. D., Histamine and histamine receptor antagonists in cancer biology. Inflammation and Allergy-Drug Targets 2010 9 3 146 157 2-s2.0-77958495125
14. Vidal Pan C., González Quintela A., Galdos Anuncibay P., Mateo Vic J., Topical promethazine intoxication. Current Medical Research and Opinion 2012 28 4 623 642
15. Yanai K., Anticholinergic activity of antihistamines. Clinical Neurophysiology 2012 123 4 633 634 2-s2.0-84857784121 10.1016/j.clinph.2011.09. 005
16. Wang X.-C., Hong J.-G., Yang X.-Q., Discussions on the use of promethazine. Chinese Journal of Pediatrics 2010 48 7 557 558 2-s2.0-79953018839
17. Promethazine should not be used for infants. Pharmazie 2010 65 5 339 342
18. Al Khaja K. A. J., Al Ansari T. M., Damanhori A. H. H., Sequeira R. P., Evaluation of drug utilization and prescribing errors in infants: a primary care prescription-based study. Health Policy 2007 81 2-3 350 357 2-s2.0-33947209448 10.1016/j.healthpol.2006.07.001 (Pubitemid 46436188)
19. Cohen M. R., Frequency and severity of promethazine adverse event reports obligated the ISMP alert. Joint Commission Journal on Quality and Patient Safety 2010 36 3 143 144 2-s2.0-77951232014
20. Lazarou J., Pomeranz B. H., Corey P. N., Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. Journal of the American Medical Association 1998 279 15 1200 1205 2-s2.0-0032522873 10.1001/jama.279.15.1200 (Pubitemid 28193431)
21. Gandhi T. K., Weingart S. N., Borus J., Seger A. C., Peterson J., Burdick E., Seger D. L., Shu K., Federico F., Leape L. L., Bates D. W., Adverse drug events in ambulatory care. The New England Journal of Medicine 2003 348 16 1556 1564 2-s2.0-0037451920 10.1056/NEJMsa020703 (Pubitemid 36437933)
22. Vervloet D., Durham S., ABC of allergies: adverse reactions to drugs. British Medical Journal 1998 316 7143 1511 1514 2-s2.0-0032537307 (Pubitemid 28224967)
23. Sylvia L. M., Tisdale J. E., Miller D. A., Drug allergy, pseudoallergy, and cutaneous diseases. Drug-Induced Diseases: Prevention, Detection, and Management 2010 2nd Bethesda, Md, USA American Society of Health-System Pharmacists
24. Kai Y., Okamoto O., Fujiwara S., Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole. Clinical and Experimental Dermatology 2011 36 7 755 758 2-s2.0-80052992415 10.1111/j.1365-2230.2011.04093.x
25. Cohen M. R., Frequency and severity of promethazine adverse event reports obligated the ISMP alert. Joint Commission Journal on Quality and Patient Safety 2010 36 3 143 144 2-s2.0-77951232014
26. Palop V., Pastor C., Rubio E., Martinez-Mir I., Topical antihistamines: is their use justified? Atencion Primaria 1996 18 1 47 48 2-s2.0-0029979947 (Pubitemid 26199234)
27. Riedl M. A., Casillas A. M., Adverse drug reactions: types and treatment options. American Family Physician 2003 68 9 1781 1790 2-s2.0-0242676078 (Pubitemid 37385772)
28. Gell P. G. H., Coombs R. R. A., Clinical Aspects of Immunology 1975 3rd Oxford, UK Blackwell Scientific
29. Pichler W. J., Delayed drug hypersensitivity reactions. Annals of Internal Medicine 2003 139 8 683 I46 2-s2.0-0142087834
30. Posadas S. J., Pichler W. J., Delayed drug hypersensitivity reactions-new concepts. Clinical and Experimental Allergy 2007 37 7 989 999 2-s2.0-34250784647 10.1111/j.1365-2222.2007.02742.x (Pubitemid 46955519)
31. Friedmann P. S., Ardern-Jones M., Patch testing in drug allergy. Current Opinion in Allergy and Clinical Immunology 2010 10 291 296
32. Schnyder B., Approach to the patient with drug allergy. Immunology and Allergy Clinics of North America 2009 29 405 418
33. Barranco P., López-Serrano M. C., General and epidemiological aspects of allergic drug reactions. Clinical and Experimental Allergy 1998 28 supplement 4 61 62 2-s2.0-0031679473
34. Adkinson N. F., Risk factors for drug allergy. Journal of Allergy and Clinical Immunology 1984 74 4 567 572 2-s2.0-0021678794 (Pubitemid 15200690)
35. Pirmohamed M., Park B. K., Adverse drug reactions: back to the future. British Journal of Clinical Pharmacology 2003 55 5 486 492 10.1046/j.1365-2125. 2003.01847.x (Pubitemid 36645404)
36. Hindsén M., Isaksson M., Persson L., Zimersson E., Bruze M., Photoallergic contact dermatitis from ketoprofen induced by drug-contaminated personal objects. Journal of the American Academy of Dermatology 2004 50 2 215 219 2-s2.0-0842310851 10.1016/j.jaad.2003.07.007 (Pubitemid 38174278)
37. Le Coz C. J., Bottlaender A., Scrivener J.-N., Santinelli F., Cribier B. J., Heid E., Grosshans E. M., Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis 1998 38 5 245 252 2-s2.0-0031746927 10.1111/j.1600-0536.1998.tb05737. x (Pubitemid 28274277)
38. Mirakian R., Ewan P. W., Durham S. R., Youlten L. J. F., Dugué P., Friedmann P. S., English J. S., Huber P. A. J., Nasser S. M., BSACI guidelines for the management of drug allergy. Clinical and Experimental Allergy 2009 39 1 43 61 2-s2.0-58149214213 10.1111/j.1365-2222.2008.03155.x
39. Barbaud A., Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005 209 2 209 216 2-s2.0-17644371364 10.1016/j.tox.2004.12.024 (Pubitemid 40568653)